Baxter and Althin dialalizers: (1) a-11, (2) a-15, (3) a-18, (4) a-22, (5) af-150, (6) All batches with the following product codes: (1) unidentified, (2) 237015, (3) 237018, (4) 237022, (5) 238015, (8) ax1500, (9) ax2200, (6) 238018, (7) 238022, (8 and 9) 239015, 239022, 239522 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Baxter International Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    386
  • 날짜
    2001-11-16
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    UNTIL THIS DATE DOES NOT CONSERT PRODUCT REGISTRATION IN BRAZIL
  • 원인
    Baxter international has announced the discovery of a probable cause for the deaths of the 53 patients who occurred during the past month in establishments that use the above dialyzers. after extensive research, baxter discovered that the problem occurred in dialyzers containing perfluorohydrocarbon, a fluid used in the manufacture of about 10% of dialyzers manufactured at baxter's ronneby facility in sweden. perfluorohydrocarbon is a liquid at room temperature but turns into gas if it is warmed to body temperature, meaning that gas bubbles may have entered the bloodstream during hemodialysis, resulting in death of patients. perfluorohydrocarbon is not used in the manufacturing process for other dialyzers that baxter manufactures or distributes. baxter international has announced that it will permanently discontinue this way of manufacturing dialyzers as a precautionary measure. baxter, the fda and international regulatory agencies are continuing investigations to see if chemical fluid has been used by other filter manufacturers and whether other patients may have been affected. baxter international inc [305486], one baxter pkwy, deerfield il 60015.
  • 조치
    After numerous investigations, Baxter identifies probable cause of recent deaths from hemodialysis patients [online news]. 5 November 2001 [quoted on November 8, 2001]. Available on the Internet: http://www.baxter.com/utilities/news/releases/2001/11-05dialyzer.html; U.S. Food and Drug Administration. FDA investigating the role of Baxter dialyzers in the deaths of patients on dialysis [online]. 7 November 2001 [quoted on November 8, 2001]. Available online: http://www.fda.gov/cdrh/recalls/dialyzers110701.html; Peterson M, Daly E. Baxter finds possible link between the 53 deaths [online]. NY Times November 6, 2001 [quoted on November 6, 2001]. Available on the Internet: http://www.nytimes.com Check for the receipt of the correction letter and response form dated October 18, 2001 from Baxter. Identify and isolate all affected products from your inventory. Baxter recommends that you suspend the use of all of the above products. Complete and return the answer form by fax 1 (847) 270-5457. If you have distributed these dialyzers to others, please send the correction letter and the response form to them immediately. For more information, please contact your local representative. Notify any occurrences associated with these products, to ANVISA, Technovigilance Unit, filling out the Health Product Associated Notifications Form available on the Internet http://www.anvisa.gov.br/tecnovigilancia and send directly online or save the file completed and send by e-mail tecnovigilância@anvisa.gov.br, or print it and send by fax 0xx61-4481257

Manufacturer

  • Source
    ANVSANVISA